AN2 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	18	21.35	15.65	27.22	12.1	4.07
Short-Term Investments	43.92	62.27	91.65	68.84	46.46	-
Cash & Short-Term Investments	61.92	83.62	107.3	96.06	58.56	4.07
Cash Growth	-33.72%	-22.07%	11.70%	64.05%	1338.70%	-27.30%
Other Receivables	0.6	0.3	1.4	-	-	-
Receivables	0.6	0.3	1.4	-	-	-
Prepaid Expenses	1.5	2.34	1.81	2.51	1.55	0.16
Other Current Assets	-	-	-	0.05	-	-
Total Current Assets	64.02	86.26	110.51	98.62	60.11	4.23
Long-Term Investments	3.22	5.02	27.19	3.22	3.49	-
Long-Term Deferred Charges	-	-	-	-	1.72	-
Other Long-Term Assets	-	0.8	1.04	0.72	-	-
Total Assets	67.24	92.09	138.74	102.56	65.32	4.23
Accounts Payable	2.23	3.32	2.68	2.12	1.06	0.13
Accrued Expenses	4.45	6.13	10.7	5.01	2	1.31
Current Portion of Leases	-	-	-	0.05	-	-
Other Current Liabilities	0.18	0.79	0.67	0.01	0.33	0.01
Total Current Liabilities	6.86	10.24	14.04	7.19	3.4	1.46
Other Long-Term Liabilities	-	-	-	0	0.01	0.02
Total Liabilities	6.86	10.24	14.04	7.19	3.41	1.48
Additional Paid-In Capital	292.55	287.59	278.88	185.47	-	-
Retained Earnings	-232.24	-205.78	-154.46	-89.72	-47.38	-20.32
Comprehensive Income & Other	0.06	0.03	0.28	-0.37	-0.03	-
Total Common Equity	60.38	81.85	124.7	95.37	-47.41	-20.32
Shareholders' Equity	60.38	81.85	124.7	95.37	61.91	2.75
Total Liabilities & Equity	67.24	92.09	138.74	102.56	65.32	4.23
Total Debt	-	-	-	0.05	-	-
Net Cash (Debt)	61.92	83.62	107.3	96.01	58.56	4.07
Net Cash Growth	-33.72%	-22.07%	11.76%	63.96%	1338.70%	-16.43%
Net Cash Per Share	2.06	2.80	4.55	6.26	22.20	1.58
Filing Date Shares Outstanding	27.4	30.1	29.77	19.4	2.73	2.71
Total Common Shares Outstanding	27.37	29.92	29.74	19.4	2.73	2.71
Working Capital	57.16	76.02	96.46	91.44	56.71	2.78
Book Value Per Share	2.21	2.74	4.19	4.92	-17.36	-7.50
Tangible Book Value	60.38	81.85	124.7	95.37	-47.41	-20.32
Tangible Book Value Per Share	2.21	2.74	4.19	4.92	-17.36	-7.50

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q